 |
|
| ANTICANCER DRUG DEVELOPMENT
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
Bruce Baguley, The University of Auckland, New Zealand
David Kerr, University of Oxford, United Kingdom
Description
Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary
fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction,
the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical
trial design are also provided.
Audience
Oncologists, cancer researchers, pharmacologists, molecular biologists, and cell biologists.
| Bibliographic details |
Hardbound, 397 pages, publication date: OCT-2001
ISBN-13: 978-0-12-072651-6
ISBN-10: 0-12-072651-3
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 149
EUR 108.95
GBP 92
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 7 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company